Kai Blöndal

504 total citations
14 papers, 266 citations indexed

About

Kai Blöndal is a scholar working on Infectious Diseases, Epidemiology and Surgery. According to data from OpenAlex, Kai Blöndal has authored 14 papers receiving a total of 266 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Infectious Diseases, 10 papers in Epidemiology and 2 papers in Surgery. Recurrent topics in Kai Blöndal's work include Tuberculosis Research and Epidemiology (14 papers), Pneumonia and Respiratory Infections (6 papers) and Pneumocystis jirovecii pneumonia detection and treatment (4 papers). Kai Blöndal is often cited by papers focused on Tuberculosis Research and Epidemiology (14 papers), Pneumonia and Respiratory Infections (6 papers) and Pneumocystis jirovecii pneumonia detection and treatment (4 papers). Kai Blöndal collaborates with scholars based in Estonia, Iceland and Switzerland. Kai Blöndal's co-authors include Alan Altraja, Jaime Bayona, Ernesto Jaramillo, Rajesh Gupta, Vaira Leimane, Joia S. Mukherjee, J. Peter Cegielski, Thelma E. Tupasi, Carole D. Mitnick and Alexander Pasechnikov and has published in prestigious journals such as Emerging infectious diseases, Bulletin of the World Health Organization and Tuberculosis.

In The Last Decade

Kai Blöndal

14 papers receiving 253 citations

Peers

Kai Blöndal
Kai Blöndal
Citations per year, relative to Kai Blöndal Kai Blöndal (= 1×) peers Natalia Shubladze

Countries citing papers authored by Kai Blöndal

Since Specialization
Citations

This map shows the geographic impact of Kai Blöndal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kai Blöndal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kai Blöndal more than expected).

Fields of papers citing papers by Kai Blöndal

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kai Blöndal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kai Blöndal. The network helps show where Kai Blöndal may publish in the future.

Co-authorship network of co-authors of Kai Blöndal

This figure shows the co-authorship network connecting the top 25 collaborators of Kai Blöndal. A scholar is included among the top collaborators of Kai Blöndal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kai Blöndal. Kai Blöndal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Mehdiyev, Rafail, et al.. (2019). Rapid tests reduce the burden of tuberculosis in Azerbaijan prisons: special emphasis on rifampicin-resistance.. PubMed. 20(3). 111–120. 3 indexed citations
2.
3.
Mehdiyev, Rafail, et al.. (2017). Impact of systematic screening on the burden of tuberculosis in Azerbaijan prisons. Tuberculosis. PA2678–PA2678. 1 indexed citations
4.
Mehdiyev, Rafail, et al.. (2016). Predictors of cure in rifampicin-resistant tuberculosis in prison settings with low loss to follow-up. The International Journal of Tuberculosis and Lung Disease. 20(5). 645–651. 5 indexed citations
5.
Mehdiyev, Rafail, et al.. (2016). Interpretation of indeterminate RIF-susceptibility results obtained by rapid molecular diagnostics test. PA1907–PA1907. 2 indexed citations
7.
Blöndal, Kai, Mati Rahu, Alan Altraja, Piret Viiklepp, & Mati Rahu. (2013). Overall and cause-specific mortality among patients with tuberculosis and multidrug-resistant tuberculosis. The International Journal of Tuberculosis and Lung Disease. 17(7). 961–968. 22 indexed citations
8.
Blöndal, Kai, et al.. (2012). Predictors of recurrence of multidrug-resistant and extensively drug-resistant tuberculosis. The International Journal of Tuberculosis and Lung Disease. 16(9). 1228–1233. 19 indexed citations
9.
Blöndal, Kai, et al.. (2011). Countrywide management of pulmonary tuberculosis reverses increasing incidence. The International Journal of Tuberculosis and Lung Disease. 15(7). 892–898. 7 indexed citations
10.
Ásgeirsson, Hilmir, Kai Blöndal, Þorsteinn Blöndal, & Magnús Gottfreðsson. (2009). [Multidrug resistant tuberculosis in Iceland--case series and review of the literature].. PubMed. 95(7-8). 499–507. 4 indexed citations
11.
Blöndal, Kai. (2007). Barriers to reaching the targets for tuberculosis control: multidrug-resistant tuberculosis.. PubMed. 85(5). 387–90; discussion 391. 28 indexed citations
12.
Blöndal, Kai. (2007). La tuberculosis multirresistente, un obstáculo para alcanzar las metas de la lucha antituberculosa. Bulletin of the World Health Organization. 85(5). 387–390. 1 indexed citations
13.
Blöndal, Kai. (2007). Barriers to reaching the targets for tuberculosis control: multidrug-resistant tuberculosis. Bulletin of the World Health Organization. 85(5). 387–390. 30 indexed citations
14.
Rich, Michael, Rajesh Gupta, Jaime Bayona, et al.. (2006). Multidrug-resistant Tuberculosis Management in Resource-limited Settings. Emerging infectious diseases. 12(7). 1389–1397. 134 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026